Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 237 articles:
HTML format



Single Articles


    July 2021
  1. HARRISON N, Humes R, Singla M
    Skip, Stop, Switch, and Spare: Steroid Therapy in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00049.
    PubMed    


    June 2021
  2. ABDALLA MI, Levesque BG
    Progress in Corticosteroid Use in the Era of Biologics With Room for Improvement.
    Am J Gastroenterol. 2021;116:1187-1188.
    PubMed     Abstract available


  3. TARGOWNIK LE, Bernstein CN, Benchimol EI, Kaplan GG, et al
    Trends in Corticosteroid Use During the Era of Biologic Therapy: A Population-Based Analysis.
    Am J Gastroenterol. 2021;116:1284-1293.
    PubMed     Abstract available


    May 2021
  4. DE GIORGI V, Trane L, Silvestri F, Venturi F, et al
    Pyodermatitis-Pyostomatitis Vegetans in Active Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 May 31. pii: 00000434-900000000-98762.
    PubMed    


  5. BOTWIN GJ, Li D, Figueiredo J, Cheng S, et al
    Adverse Events Following SARS-CoV-2 mRNA Vaccination: Among Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98766.
    PubMed     Abstract available


  6. TEICH N, Stallmach A, Bruns T
    Greenspace in Childhood: A New Avenue to Prevent Inflammatory Bowel Disease?
    Am J Gastroenterol. 2021 May 7. pii: 00000434-900000000-98784.
    PubMed    


  7. TANG J, Huang Z, Guo H, Ding N, et al
    Online Video Clinic Satisfies the Medical Requirements of Patients with IBD During the COVID-19 Outbreak.
    Am J Gastroenterol. 2021;116:1087.
    PubMed    


  8. PAPAMICHAEL K, Vande Casteele N, Jeyarajah J, Jairath V, et al
    Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.
    Am J Gastroenterol. 2021;116:1007-1014.
    PubMed     Abstract available


    April 2021
  9. KHAN N, Patel D, Xie D, Pernes T, et al
    Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.
    Am J Gastroenterol. 2021;116:808-810.
    PubMed     Abstract available


  10. KHAN N, Patel D, Trivedi C, Kavani H, et al
    Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Am J Gastroenterol. 2021;116:741-747.
    PubMed     Abstract available


  11. SONNENBERG A
    Do Forgotten Symptoms Need Treatment?
    Am J Gastroenterol. 2021;116:841-842.
    PubMed    


  12. HA C
    The Age-Old Conundrum With Thiopurines: Are the Accumulating Risks Greater Than Benefits?
    Am J Gastroenterol. 2021;116:671-672.
    PubMed     Abstract available


    March 2021
  13. BERNSTEIN CN, Nugent Z, Singh H
    Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study.
    Am J Gastroenterol. 2021 Mar 24. pii: 00000434-900000000-98845.
    PubMed     Abstract available


  14. SLATER NR, Loomes DE
    Endoscopic Vacuum-Assisted Wound Closure of a Rectal Perforation in the Setting of Active Ulcerative Colitis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98819.
    PubMed    


    January 2021
  15. COELHO-PRABHU N, Kane S
    Does Size Really Matter?
    Am J Gastroenterol. 2021;116:84-85.
    PubMed     Abstract available


  16. HAMMOUDI N, Allez M
    Response to Hanzel.
    Am J Gastroenterol. 2021;116:218.
    PubMed    


  17. HANZEL J
    A Novel Endoscopic Score for Postoperative Recurrence of Crohn's Disease: More Information Needed.
    Am J Gastroenterol. 2021;116:217-218.
    PubMed    


  18. RIVIERE P, D'Haens G, Peyrin-Biroulet L, Baert F, et al
    Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
    Am J Gastroenterol. 2021;116:134-141.
    PubMed     Abstract available


    December 2020
  19. LACY BE, Pimentel M, Brenner DM, Chey WD, et al
    ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2020 Dec 14. doi: 10.14309/ajg.0000000000001036.
    PubMed     Abstract available


  20. KORELITZ BI, Sachar DB, Schneider J
    Full Potential of 6-Mercaptopurine in IBD May Remain Untapped.
    Am J Gastroenterol. 2020;115:2109-2110.
    PubMed    


  21. FERNANDA F, Mirella O, Danielle F, Pedro G, et al
    P074 Prevalence and Associated Factors With Non-Adherence to Maintenance Therapy for Ulcerative Colitis in Deep Remission.
    Am J Gastroenterol. 2020;115.
    PubMed    


  22. PRADEEP KR, Deloshaan S, Dheeraj S, Hadi M, et al
    P070 Outcomes of Acute Severe Ulcerative Colitis in Older Adults.
    Am J Gastroenterol. 2020;115.
    PubMed    


  23. DELOSHAAN S, Pradeep KR, Dheeraj S, Hadi M, et al
    P069 Admission Steroid Use, Serum Albumin and Endoscopic Severity Predict Intravenous Steroid Failure in Patients With Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  24. JAQUELINE B, Juliana C, Dos Santos B, Caroline D, et al
    P068 Therapeutic Aspects in Pediatric Inflammatory Bowel Disease - A Multi-Centric Study From Brazil.
    Am J Gastroenterol. 2020;115.
    PubMed    


  25. FLAVIA P, Cyrla Z, de Souza H, Jessica M, et al
    P066 Hospitalization and Surgery Rates in Patients With Inflammatory Bowel Disease in Brazil: A Time-Trend Analysis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  26. JENNIFER MO, Megan L, Jean A
    P065 Inflammatory Bowel Disease or Bowel Endometriosis? Two Cases of Large Bowel Obstruction.
    Am J Gastroenterol. 2020;115.
    PubMed    


  27. JAQUELINE B, Juliana C, Dos Santos Beatriz, Caroline D, et al
    P064 Clinical Aspects of Pediatric Inflammatory Bowel Disease - A Multicentric Study From Brazil.
    Am J Gastroenterol. 2020;115.
    PubMed    


  28. FABIANA B, Cesar A, Marcio C, Carolina M, et al
    P061 Prophylaxis of Hepatitis B Reactivation and Inflammatory Bowel Disease: A case report.
    Am J Gastroenterol. 2020;115.
    PubMed    


  29. SVETLANA L, Morris G, Vasiliki S
    P056 Power Calculations in Randomised Controlled Trials of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020;115.
    PubMed    


  30. WALAA M, Hisham W, Walid H, Fadi F, et al
    P049 Should the Gallbladder be Empirically Removed at Time of Intestinal Resection in Inflammatory Bowel Disease Patients?
    Am J Gastroenterol. 2020;115.
    PubMed    


  31. ERIC J
    P047 Awareness and Impact of Recent AGA Guideline Changes for Moderate to Severe Ulcerative Colitis Patients.
    Am J Gastroenterol. 2020;115.
    PubMed    


  32. ERIC J
    P046 Though Biosimilar Infliximab Prescribing in Inflammatory Bowel Disease Has Increased, Branded Infliximab Continues to Be Prescribed More Often.
    Am J Gastroenterol. 2020;115.
    PubMed    


  33. CASEY C, Jenny G, Michelle B, Joe L, et al
    P042 The CONCERT Initiative: Impact of Inflammatory Bowel Disease Care Referral Pathway.
    Am J Gastroenterol. 2020;115.
    PubMed    


  34. SARA L, Millie L, Uma M
    P040 Indications for Cesarean Section in Pregnant Women with Inflammatory Bowel Disease: Results from the PIANO Registry.
    Am J Gastroenterol. 2020;115.
    PubMed    


  35. SARA H, David H, Joe Z, Ryan H, et al
    P038 Factors Associated with Impaired Patient-Reported Outcomes and Work Productivity Among Patients with Ulcerative Colitis in Remission.
    Am J Gastroenterol. 2020;115.
    PubMed    


  36. DAVID P, Caterina O, Christopher A, Gregory AC, et al
    P037 Efficacy and Safety of 1-L NER1006 Bowel Preparation in Patients with Inflammatory Bowel Disease: Analysis of 2 Phase 3 Studies.
    Am J Gastroenterol. 2020;115.
    PubMed    


  37. CLARA U, Amanda T, Debora T, Giovana C, et al
    P036 Clinical and Psychological Factors Associated with Impaired Body Image in Patients with Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020;115.
    PubMed    


  38. KAUSTAV S, Austin T, Roman G, Allison M, et al
    P033 Demographic Factors Associated with Successful Telehealth Visits in Inflammatory Bowel Disease Patients.
    Am J Gastroenterol. 2020;115.
    PubMed    


  39. WILLIAM S, Brian F, Stephen H, Severine V, et al
    P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension.
    Am J Gastroenterol. 2020;115.
    PubMed    


  40. SILVIO D, Brian F, Stephen H, Igor J, et al
    P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  41. EDWARD B, Harris A, Joe Z, Antoine S, et al
    P027 Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD.
    Am J Gastroenterol. 2020;115.
    PubMed    


  42. SHINTARO A, Jacob O, Cindy T, Victoria R, et al
    P026 Assessment of Contributing Factors for Fistula Development in Patients with Inflammatory Bowel Disease Treated by Proctocolectomy with Ileal Pouch-Anal Anastomosis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  43. WILLIAM S, Geert D, Doug W, Stephen H, et al
    P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  44. GALIYA B, Alisa R, Maria L
    P024 Medical Decision Support System in the Diagnosis of Ulcerative Colitis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  45. MICHAEL C, Puza S, Benjamin C, Leonardo S, et al
    P021 Characteristics of Patients Treated with Tofacitinib for Ulcerative Colitis in the Real World: Findings from a Large US Claims Database.
    Am J Gastroenterol. 2020;115.
    PubMed    


  46. SUBRATA G, Geert D, Vipul J, Florian R, et al
    P012 Ozanimod Reduced Fecal Calprotectin Levels in Patients with Ulcerative Colitis in the Phase 3 True North Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  47. ROGERIO P, Julio C, Liliana C, Erika B, et al
    P008 Long-Term Effectiveness and Safety of Ustekinumab for The Treatment of Crohn s Disease: A Brazilian Multicentre Real-world Study.
    Am J Gastroenterol. 2020;115.
    PubMed    


  48. OLEG K, Albina L, Anatoliy K, Anna K, et al
    P005 Overcoming Secondary Loss of Response to Infliximab in Patients With Ulcerative Colitis With the Use of Mesenchymal Stromal Cells.
    Am J Gastroenterol. 2020;115.
    PubMed    


  49. OLEG K, Anna K, Albina L, Tatyana S, et al
    P002 Frequency and Causes of Prolongation of the Induction Course of Tofacitinib in Patients with Ulcerative Colitis.
    Am J Gastroenterol. 2020;115.
    PubMed    


  50. ERNESTO R, Rachel H, Meera L, Pablo P, et al
    P001 North-South Gradient in the Incidence of Pediatric Inflammatory Bowel Disease Along the Atlantic Coast.
    Am J Gastroenterol. 2020;115.
    PubMed    


    November 2020
  51. KHAN N, Patel D, Trivedi C, Kavani H, et al
    Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk.
    Am J Gastroenterol. 2020 Nov 26. doi: 10.14309/ajg.0000000000001058.
    PubMed     Abstract available


  52. ZAVER HB, Ghoz H, Azar A, Alexander LF, et al
    Inferior Mesenteric Arteriovenous Malformation Masquerading as Ulcerative Colitis.
    Am J Gastroenterol. 2020 Nov 10. doi: 10.14309/ajg.0000000000000917.
    PubMed    


  53. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020;115:1802-1811.
    PubMed     Abstract available


  54. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020;115:1797-1798.
    PubMed     Abstract available


  55. LITTLE DHW, Tabatabavakili S, Shaffer SR, Nguyen GC, et al
    Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review.
    Am J Gastroenterol. 2020;115:1768-1774.
    PubMed     Abstract available


  56. WINDSOR JW, Underwood FE, Brenner E, Colombel JF, et al
    Data Visualization in the Era of COVID-19: An Interactive Map of the SECURE-IBD Registry.
    Am J Gastroenterol. 2020;115:1923-1924.
    PubMed    


  57. CHAPUIS-BIRON C, Kirchgesner J, Pariente B, Bouhnik Y, et al
    Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.
    Am J Gastroenterol. 2020;115:1812-1820.
    PubMed     Abstract available


    October 2020
  58. BUCHNER AM, Schneider Y, Lichtenstein GR
    Biosimilars in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Oct 27. doi: 10.14309/ajg.0000000000000844.
    PubMed     Abstract available


  59. GUBATAN J, Nielsen OH, Levitte S, Juhl CB, et al
    Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020 Oct 23. doi: 10.14309/ajg.0000000000000910.
    PubMed     Abstract available


  60. KHAN N, Patel D, Xie D, Pernes T, et al
    Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study.
    Am J Gastroenterol. 2020 Oct 19. doi: 10.14309/ajg.0000000000001012.
    PubMed     Abstract available


  61. ELTEN M, Benchimol EI, Fell DB, Kuenzig ME, et al
    Residential Greenspace in Childhood Reduces Risk of Pediatric Inflammatory Bowel Disease: A Population-Based Cohort Study.
    Am J Gastroenterol. 2020 Oct 8. doi: 10.14309/ajg.0000000000000990.
    PubMed     Abstract available


  62. FIORINO G, Gilardi D, Radice S, Furfaro F, et al
    Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.
    Am J Gastroenterol. 2020;115:1719-1721.
    PubMed     Abstract available


  63. MANSOOR E, Khoudari G, Abou Saleh M, Elfadawy N, et al
    The Many Faces of COVID-19: Atypical Presentation of COVID-19 in a Patient With Crohn's Disease With Acute Diarrhea Leading to Severe Hypovolemic Hyponatremia-A Case Report.
    Am J Gastroenterol. 2020;115:1730-1731.
    PubMed    


  64. GIESE-KIM N, Wu M, Dehghan M, Sceats LA, et al
    Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2020;115:1698-1706.
    PubMed     Abstract available


    September 2020
  65. CHAPARRO M, Gordillo J, Domenech E, Esteve M, et al
    Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
    Am J Gastroenterol. 2020 Sep 30. doi: 10.14309/ajg.0000000000000926.
    PubMed     Abstract available


  66. BANTY A, Melmed GY
    Improving Hepatitis B Virus Vaccination Responses in Inflammatory Bowel Disease: Does Greater Dose and Greater Frequency Lead to Greater Protection?
    Am J Gastroenterol. 2020 Sep 25. doi: 10.14309/ajg.0000000000000921.
    PubMed     Abstract available


  67. SHAFFER SR, Huang E, Patel S, Rubin DT, et al
    Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
    Am J Gastroenterol. 2020 Sep 16. doi: 10.14309/ajg.0000000000000847.
    PubMed     Abstract available


  68. LONG MD
    Shining a Light on Skin Cancer in Inflammatory Bowel Disease: A Role for Prevention.
    Am J Gastroenterol. 2020 Sep 11. doi: 10.14309/ajg.0000000000000775.
    PubMed     Abstract available


  69. KAMAL N, Bookwalter A, Foss R, Cross RK, et al
    Pyostomatitis Vegetans: An Unusual Oral Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020;115:1385.
    PubMed    


  70. DALAL RS, Palchaudhuri S, Snider CK, Gitelman Y, et al
    A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2020;115:1474-1485.
    PubMed     Abstract available


  71. QUINN KP, Raffals LE
    An Update on the Medical Management of Inflammatory Pouch Complications.
    Am J Gastroenterol. 2020;115:1439-1450.
    PubMed     Abstract available


    August 2020
  72. LICHTENSTEIN GR, Rubin DT
    Coronavirus and Patients With Inflammatory Bowel Disease: Management Strategies for the Practicing Clinician.
    Am J Gastroenterol. 2020 Aug 24. doi: 10.14309/ajg.0000000000000817.
    PubMed    


  73. COHEN BL, Hanauer SB
    Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'.
    Am J Gastroenterol. 2020 Aug 20. doi: 10.14309/ajg.0000000000000809.
    PubMed    


  74. PAPA A, Gasbarrini A, Tursi A
    Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000830.
    PubMed     Abstract available


  75. RAPHAEL KL, Trindade AJ, Zimmerman HM, Sultan KS, et al
    Endoscopic Evaluation of Inflammatory Bowel Disease With High-Grade Dysplasia Should Not Be Delayed During the COVID-19 Pandemic: A Case Report.
    Am J Gastroenterol. 2020 Aug 19. doi: 10.14309/ajg.0000000000000813.
    PubMed    


  76. BERNSTEIN CN, Walld R, Marrie RA
    Social Determinants of Outcomes in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Aug 5. doi: 10.14309/ajg.0000000000000794.
    PubMed     Abstract available


  77. WOLF DC, Wolf CH, Rubin DT
    Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
    Am J Gastroenterol. 2020;115:1298.
    PubMed    


  78. NARULA N, Wong ECL, Aruljothy A, Dulai PS, et al
    Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial.
    Am J Gastroenterol. 2020;115:1236-1245.
    PubMed     Abstract available


    July 2020
  79. LITTLE DHW, Tabatabavakili S, Shaffer SR, Nguyen GC, et al
    Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review.
    Am J Gastroenterol. 2020 Jul 27. doi: 10.14309/ajg.0000000000000783.
    PubMed     Abstract available


  80. BHAT S, Farraye FA, Moss AC
    Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic.
    Am J Gastroenterol. 2020 Jul 20. doi: 10.14309/ajg.0000000000000787.
    PubMed     Abstract available


  81. HAMMOUDI N, Auzolle C, Tran Minh ML, Boschetti G, et al
    Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's Disease.
    Am J Gastroenterol. 2020;115:1084-1093.
    PubMed     Abstract available


    June 2020
  82. CALDERA F, Hayney MS, Farraye FA
    Vaccination in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2020 Jun 10. doi: 10.14309/ajg.0000000000000713.
    PubMed    


  83. YANG DH, Park SJ, Kim HS
    Response to Singh et al.
    Am J Gastroenterol. 2020;115:959-960.
    PubMed    


  84. SINGH A, Narayan J, Behera MK, Mishra D, et al
    High-Definition Chromoendoscopy Was Not Superior to High-Definition White Light Endoscopy in Detecting Colitis-Associated Dysplasia, or Was It?
    Am J Gastroenterol. 2020;115:958-959.
    PubMed    


  85. ROZICH JJ, Holmer A, Singh S
    Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2020;115:832-840.
    PubMed     Abstract available


    May 2020
  86. VASSEUR P, Dugelay E, Benamouzig R, Savoye G, et al
    Dietary Zinc Intake and Inflammatory Bowel Disease in the French NutriNet-Sante Cohort.
    Am J Gastroenterol. 2020 May 27. doi: 10.14309/ajg.0000000000000688.
    PubMed     Abstract available


  87. KHAN N, Patel D, Trivedi C, Kavani H, et al
    Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications.
    Am J Gastroenterol. 2020 May 22. doi: 10.14309/ajg.0000000000000679.
    PubMed     Abstract available


  88. DULAI PS, Battat R, Barsky M, Nguyen NH, et al
    Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
    Am J Gastroenterol. 2020 May 7. doi: 10.14309/ajg.0000000000000596.
    PubMed     Abstract available


  89. SANDS BE, Feagan BG, Sandborn WJ, Schreiber S, et al
    Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study.
    Am J Gastroenterol. 2020;115:738-745.
    PubMed     Abstract available


  90. BEWTRA M, Lichtenstein GR
    Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease Therapy.
    Am J Gastroenterol. 2020;115:687-688.
    PubMed     Abstract available


  91. LEE MW, Pourmorady JS, Laine L
    Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020;115:662-670.
    PubMed     Abstract available


    April 2020
  92. MIRANDA E, Meza R, Kolbach M, Torres J, et al
    Sweet Syndrome in Pediatric Active Ulcerative Colitis.
    Am J Gastroenterol. 2020 Apr 27. doi: 10.14309/ajg.0000000000000645.
    PubMed    


  93. LIMDI JK
    Continuing Medical Education Questions: April 2020: Men with Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
    Am J Gastroenterol. 2020;115:506.
    PubMed    


  94. GANZLEBEN I, Hirschmann S, Kohler J, Fuchs FS, et al
    Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy.
    Am J Gastroenterol. 2020;115:632-634.
    PubMed    


    March 2020
  95. SHAH A, Macdonald GA, Morrison M, Holtmann G, et al
    Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework.
    Am J Gastroenterol. 2020 Mar 25. doi: 10.14309/ajg.0000000000000604.
    PubMed     Abstract available


    February 2020
  96. KEDIA S, Mouli VP, Kamat N, Sankar J, et al
    Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020 Feb 6. doi: 10.14309/ajg.0000000000000527.
    PubMed     Abstract available


  97. HAMMAMI MB, Mahadevan U
    Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
    Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000515.
    PubMed     Abstract available


    January 2020
  98. TARGOWNIK LE, Kaplan GG, Witt J, Bernstein CN, et al
    Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Am J Gastroenterol. 2020;115:128-137.
    PubMed     Abstract available


    December 2019
  99. CHATEAU T, Feakins R, Marchal-Bressenot A, Magro F, et al
    Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure.
    Am J Gastroenterol. 2019 Dec 5. doi: 10.14309/ajg.0000000000000437.
    PubMed     Abstract available


    November 2019
  100. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available


  101. LEI DK, Ollech JE, Andersen M, Weisshof R, et al
    Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    Am J Gastroenterol. 2019 Nov 7. doi: 10.14309/ajg.0000000000000460.
    PubMed     Abstract available


  102. AGRAWAL S, Khanna U, Fernandez AP, Irfan M, et al
    Linear Immunoglobulin A Bullous Dermatosis Associated With Ulcerative Colitis.
    Am J Gastroenterol. 2019 Nov 6. doi: 10.14309/ajg.0000000000000449.
    PubMed    


  103. BOOTH AT, Forster E, Curran T, George V, et al
    Gastrocolic Fistula Involving the Pancreas in a Patient With Crohn's Disease.
    Am J Gastroenterol. 2019;114:1823-1824.
    PubMed    


    October 2019
  104. VISCIDO A, Latella G, Frieri G
    Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000427.
    PubMed    


  105. YANG DH, Park SJ, Kim HS, Park YS, et al
    High-Definition Chromoendoscopy Versus High-Definition White Light Colonoscopy for Neoplasia Surveillance in Ulcerative Colitis: A Randomized Controlled Trial.
    Am J Gastroenterol. 2019;114:1642-1648.
    PubMed     Abstract available


    September 2019
  106. COHEN ER, Salem M, Ha C
    Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak.
    Am J Gastroenterol. 2019 Sep 6. doi: 10.14309/ajg.0000000000000396.
    PubMed    


  107. WALLENHORST T, Jacques J, Bouguen G, Pagenault M, et al
    Successful Closure of a Rectal Fistula of Crohn's Disease Using Endoscopic Submucosal Dissection Combined With an Over-the-Scope Clip.
    Am J Gastroenterol. 2019;114:1416.
    PubMed    


    August 2019
  108. GREUTER T, Vavricka SR, Scharl M
    Response to Al Sulais et al.
    Am J Gastroenterol. 2019;114:1346-1347.
    PubMed    


  109. AL SULAIS E, AlAmeel T
    Family History Is a Risk Factor for Developing Malignancies.
    Am J Gastroenterol. 2019;114:1346.
    PubMed    


  110. SIMSEK M, de Boer NKH
    Mesalazine and Nephrolithiasis: Leave No Stone Unturned.
    Am J Gastroenterol. 2019;114:1359-1360.
    PubMed    


  111. LU C, Holubar SD, Rieder F
    How I Approach the Management of Stricturing Crohn's Disease.
    Am J Gastroenterol. 2019;114:1181-1184.
    PubMed    


    July 2019
  112. LIAO KF, Lai SW
    Association Between Inflammatory Bowel Disease and Hip Fracture.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000344.
    PubMed    


  113. BAR-GIL SHITRIT A, Ben Ya'acov A, Livovsky DM, Cuker T, et al
    Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study.
    Am J Gastroenterol. 2019;114:1172-1175.
    PubMed     Abstract available


  114. BRAUN T, Di Segni A, BenShoshan M, Neuman S, et al
    Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares.
    Am J Gastroenterol. 2019;114:1142-1151.
    PubMed     Abstract available


  115. BISHNOI A, Kaushik A, Banerjee N, Nada R, et al
    Asymptomatic Macrocheilia in an Adult Woman.
    Am J Gastroenterol. 2019;114:1022.
    PubMed    


    June 2019
  116. KNOX NC, Forbes JD, Peterson CL, Van Domselaar G, et al
    The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Am J Gastroenterol. 2019 Jun 20. doi: 10.14309/ajg.0000000000000305.
    PubMed     Abstract available


  117. PITTET LF, Verolet CM, Michetti P, Girardin M, et al
    High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jun 13. doi: 10.14309/ajg.0000000000000289.
    PubMed     Abstract available


    May 2019
  118. MANOSA M, Chaparro M, Juan A, Arajol C, et al
    Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers.
    Am J Gastroenterol. 2019;114:771-776.
    PubMed     Abstract available


  119. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Chapman and Jones.
    Am J Gastroenterol. 2019;114:828.
    PubMed    


  120. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Ribaldone.
    Am J Gastroenterol. 2019;114:826-827.
    PubMed    


  121. CHAPMAN BJ, Jones GB
    Underscoring the Biochemical Overlap Between Crohn's Disease and Depression.
    Am J Gastroenterol. 2019;114:827-828.
    PubMed    


  122. RIBALDONE DG
    ACG Clinical Guideline on Crohn's Disease: A Point of View from Europe.
    Am J Gastroenterol. 2019;114:826.
    PubMed    


  123. WU J, Lubman DM, Kugathasan S, Denson LA, et al
    Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
    Am J Gastroenterol. 2019;114:777-785.
    PubMed     Abstract available


    April 2019
  124. SINGH S, Proudfoot J, Dulai PS, Jairath V, et al
    Correction: No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2019 Apr 29. doi: 10.14309/ajg.0000000000000254.
    PubMed    


  125. LONG MD, Rubin DT
    Histologic Remission in Ulcerative Colitis: Are We There Yet?
    Am J Gastroenterol. 2019 Apr 22. doi: 10.14309/ajg.0000000000000235.
    PubMed     Abstract available


  126. MENON T, Afzali A
    Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care.
    Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000222.
    PubMed     Abstract available


  127. JAIN A, Nguyen NH, Proudfoot JA, Martin CF, et al
    Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2019;114:630-639.
    PubMed     Abstract available


    March 2019
  128. UNGARO R, Colombel JF, Lissoos T, Peyrin-Biroulet L, et al
    A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review.
    Am J Gastroenterol. 2019 Mar 22. doi: 10.14309/ajg.0000000000000183.
    PubMed     Abstract available


  129. BARNES EL, Kappelman MD, Long MD, Evon DM, et al
    A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Mar 1. doi: 10.14309/ajg.0000000000000177.
    PubMed     Abstract available


  130. RUBIN DT, Ananthakrishnan AN, Siegel CA, Sauer BG, et al
    ACG Clinical Guideline: Ulcerative Colitis in Adults.
    Am J Gastroenterol. 2019;114:384-413.
    PubMed     Abstract available


  131. SINGH S, Jairath V
    Response to Gupta and Hanauer.
    Am J Gastroenterol. 2019;114:535-536.
    PubMed    


  132. HE Y, Zhu Z, Chen Y, Chen F, et al
    Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.
    Am J Gastroenterol. 2019;114:490-499.
    PubMed     Abstract available


  133. GUPTA N, Hanauer SB
    Too Soon to Discard 5-ASAs?
    Am J Gastroenterol. 2019;114:534-535.
    PubMed    


    February 2019
  134. HATA K, Anzai H, Ikeuchi H, Futami K, et al
    Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.
    Am J Gastroenterol. 2019 Feb 8. doi: 10.14309/ajg.0000000000000117.
    PubMed     Abstract available


  135. LUDVIGSSON JF, Mahl M, Sachs MC, Bjork J, et al
    Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014.
    Am J Gastroenterol. 2019;114:291-304.
    PubMed     Abstract available


  136. FRIEDMAN S, Norgard BM
    Response to Zhao et al.
    Am J Gastroenterol. 2019;114:358-359.
    PubMed    


  137. BERENBLUM C
    An Issue of Control: Patient Perspectives on Use of Nutritional Interventions for IBD.
    Am J Gastroenterol. 2019;114:192-193.
    PubMed    


    January 2019
  138. SIEGEL CA
    Placing Value on Telemedicine for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jan 30. doi: 10.14309/ajg.0000000000000151.
    PubMed     Abstract available


  139. BATTAT R, Duijvestein M, Guizzetti L, Choudhary D, et al
    Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2019 Jan 25. doi: 10.14309/ajg.0000000000000111.
    PubMed     Abstract available


  140. ZHAO S, Wang J, Zhao Z
    Inflammatory Bowel Disease and Risk of Erectile Dysfunction: What Does the Current Evidence Tell Us?
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000070.
    PubMed    


  141. LICHTENSTEIN GR, Loftus EV Jr, Isaacs KL, Regueiro MD, et al
    Response to Chamberlin and Borody.
    Am J Gastroenterol. 2019;114:171-174.
    PubMed    


  142. CHAMBERLIN W, Borody T
    Comment on 2018 ACG Clinical Guideline: Antibiotics in Crohn's Disease.
    Am J Gastroenterol. 2019;114:170-171.
    PubMed    


  143. SAEZ-GONZALEZ E, Salavert M, Cerrillo E, Moret I, et al
    Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome: Life-Threatening Complications of Anti-TNF-alpha Treatment for Crohn's Disease.
    Am J Gastroenterol. 2019;114:177-179.
    PubMed    


  144. LIU PH, Lebwohl B, Burke KE, Ivey KL, et al
    Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study.
    Am J Gastroenterol. 2019;114:127-134.
    PubMed     Abstract available


    November 2018
  145. SHEN B, Kochhar G, Hull TL
    Bridging Medical and Surgical Treatment of Inflammatory Bowel Disease: The Role of Interventional IBD.
    Am J Gastroenterol. 2018 Nov 21. pii: 10.1038/s41395-018-0416.
    PubMed    


  146. VERNERO M, Astegiano M, Ribaldone DG
    New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0422.
    PubMed    


  147. COHEN-MEKELBURG S, Rosenblatt R, Gold S, Shen N, et al
    Fragmented Care is Prevalent among Inflammatory Bowel Disease Readmissions and is Associated with Worse Outcomes.
    Am J Gastroenterol. 2018 Nov 12. pii: 10.1038/s41395-018-0417.
    PubMed     Abstract available


  148. CROSS RK, Langenberg P, Regueiro M, Schwartz DA, et al
    A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0272.
    PubMed     Abstract available


  149. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Nov 2. pii: 10.1038/s41395-018-0401.
    PubMed     Abstract available


    October 2018

  150. Inflammatory Bowel Disease (Abstracts 568-744).
    Am J Gastroenterol. 2018 Oct 25. pii: 10.1038/s41395-018-0296.
    PubMed    


  151. CHAPARRO M, Gisbert JP
    Pregnancy and Inflammatory Bowel Disease: A Long Way to Go.
    Am J Gastroenterol. 2018 Oct 24. pii: 10.1038/s41395-018-0379.
    PubMed    


  152. BYE WA, Ma C, Nguyen TM, Parker CE, et al
    Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0354.
    PubMed     Abstract available


  153. MA D, Wong W, Aviado J, Rodriguez C, et al
    Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0368.
    PubMed     Abstract available


  154. SCHARL S, Barthel C, Rossel JB, Biedermann L, et al
    Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0360.
    PubMed     Abstract available



  155. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0312.
    PubMed    



  156. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0342.
    PubMed    



  157. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0327.
    PubMed    


    September 2018
  158. ALMARIO CV, Chen MS, Spiegel BMR
    Reply to Johnson et al. Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Sep 13. pii: 10.1038/s41395-018-0279.
    PubMed    


  159. NG SC, Kaplan GG, Tang W, Banerjee R, et al
    Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0233.
    PubMed     Abstract available


    August 2018
  160. JAIRATH V
    Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.
    Am J Gastroenterol. 2018 Aug 29. pii: 10.1038/s41395-018-0224.
    PubMed     Abstract available


  161. AXELRAD JE, Joelson A, Green PHR, Lawlor G, et al
    Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Aug 3. pii: 10.1038/s41395-018-0211.
    PubMed     Abstract available


    July 2018
  162. FELD LD, Rubin DT, Feld AD
    Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
    Am J Gastroenterol. 2018 Jul 16. pii: 10.1038/s41395-018-0204.
    PubMed    


  163. FRIEDMAN S, Magnussen B, O'Toole A, Fedder J, et al
    Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Am J Gastroenterol. 2018 Jul 10. pii: 10.1038/s41395-018-0177.
    PubMed     Abstract available


  164. JOHNSON FR, Reed S, Gonzalez JM
    Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Jul 3. pii: 10.1038/s41395-018-0186.
    PubMed    


    June 2018
  165. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0162.
    PubMed     Abstract available


  166. SINGH S, Proudfoot JA, Dulai PS, Jairath V, et al
    No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0144.
    PubMed     Abstract available


  167. NHU QM, Chiao H, Moawad FJ, Bao F, et al
    The Anti-alpha4beta7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0145.
    PubMed    


  168. LEVENSTEIN S, Prantera C
    Depression and Disease Course in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0111.
    PubMed    


  169. MAO R, Chen MH
    Networked Clinical Study Collaboration on Inflammatory Bowel Disease in China.
    Am J Gastroenterol. 2018 Jun 7. pii: 10.1038/s41395-018-0148.
    PubMed    


  170. MOHAPATRA S, Singh DP, Alcid D, Pitchumoni CS, et al
    Beyond O&P Times Three.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0083.
    PubMed     Abstract available


    May 2018
  171. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0057.
    PubMed     Abstract available


  172. SCHILLER LR
    Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0032.
    PubMed     Abstract available


    April 2018
  173. MATSUSHITA M, Fukata N, Omiya M, Nishio A, et al
    Pathophysiology of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:622.
    PubMed    


    March 2018
  174. JENSEN CB, Angquist LH, Mendall MA, Sorensen TIA, et al
    Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0031.
    PubMed     Abstract available


  175. DEEKE SA, Starr AE, Ning Z, Ahmadi S, et al
    Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis.
    Am J Gastroenterol. 2018 Mar 12. pii: 10.1038/s41395-018-0024.
    PubMed     Abstract available


  176. VEERAPPAN GR
    Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018;113:404.
    PubMed    


    February 2018
  177. DAI C, Jiang M, Cao Q
    Association between Depression and More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0016.
    PubMed    


  178. CHAPARRO M, Verreth A, Lobaton T, Gravito-Soares E, et al
    Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg2017501. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  179. GRACIE DJ, Hamlin PJ, Ford AC
    Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0021.
    PubMed     Abstract available


  180. DULAI PS, Buckey JC Jr., Raffals LE, Swoger JM, et al
    Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0005.
    PubMed     Abstract available


  181. BARNES EL, Kappelman MD
    Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.
    Am J Gastroenterol. 2018;113:273-275.
    PubMed     Abstract available


  182. TOMINAGA K, Tsuchiya A, Honda Y, Abe T, et al
    A Case of Panenteritis With Massive IgG4-Positive Plasma Cell Infiltration Developed 26 Years After Total Proctocolectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:173.
    PubMed    


    January 2018
  183. LEWIS JD, Scott FI, Brensinger CM, Roy JA, et al
    Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jan 16. pii: ajg2017479. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  184. JEURING SFG, Biemans VBC, van den Heuvel TRA, Zeegers MP, et al
    Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2018 Jan 9. pii: ajg2017482. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    December 2017
  185. TAKENAKA K, Ohtsuka K, Kitazume Y, Matsuoka K, et al
    Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017464. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  186. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  187. MA C, Moran GW, Benchimol EI, Targownik LE, et al
    Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.
    Am J Gastroenterol. 2017;112:1840-1848.
    PubMed     Abstract available


    November 2017
  188. KOCHAR B, Barnes EL, Long MD, Cushing KC, et al
    Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  189. CLICK B, Anderson AM, Koutroubakis IE, Rivers CR, et al
    Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.
    Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  190. BERNSTEIN CN, Kornbluth A
    Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1719-1721.
    PubMed     Abstract available


  191. ABE K, Nakamura N, Isono A, Toyota H, et al
    Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
    Am J Gastroenterol. 2017;112:1636.
    PubMed    


    October 2017
  192. MARTIN L, Peche W, Peterson K, Wan Y, et al
    Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Abstract available



  193. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    



  194. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    



  195. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    



  196. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    


  197. FISCHER S, Rath T, Geppert CI, Manger B, et al
    Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1621-1623.
    PubMed    


  198. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.
    PubMed    


  199. BUCHNER AM, Lichtenstein GR
    Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Am J Gastroenterol. 2017;112:1593-1595.
    PubMed     Abstract available


  200. KHANNA R, Zou G, Stitt L, Feagan BG, et al
    Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Am J Gastroenterol. 2017;112:1584-1592.
    PubMed     Abstract available


    September 2017
  201. ESTEVEZ-BOULLOSA P, Fernandez-Fernandez N, Pineda-Marino JR, Martinez-Cadilla J, et al
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1363.
    PubMed    


  202. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017;112:1485.
    PubMed     Abstract available


    August 2017
  203. GHIONE S, Sarter H, Fumery M, Armengol-Debeir L, et al
    Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    July 2017
  204. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017 Jul 25. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  205. YAMADA A, Komaki Y, Patel N, Komaki F, et al
    Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  206. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  207. DAI C, Jiang M, Sun MJ
    The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1165.
    PubMed    


  208. MATSUSHITA M, Fukata N, Omiya M, Okazaki K, et al
    Nationwide Studies of Hematological Malignancies in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1171-1172.
    PubMed    


    June 2017
  209. MYRELID P, Landerholm K, Nordenvall C, Pinkney TD, et al
    Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study.
    Am J Gastroenterol. 2017 Jun 27. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  210. PATIL DT, Odze RD
    Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jun 20. doi: 10.1038/ajg.2017.
    PubMed    


  211. KOMEDA Y, Kashida H, Sakurai T, Kono M, et al
    A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:833.
    PubMed    


    May 2017
  212. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  213. CHAPARRO M, Ramas M, Benitez JM, Lopez-Garcia A, et al
    Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    April 2017
  214. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    March 2017
  215. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed    


  216. LIMSRIVILAI J, Shreiner AB, Pongpaibul A, Laohapand C, et al
    Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Am J Gastroenterol. 2017;112:415-427.
    PubMed     Abstract available


    February 2017
  217. FUMERY M, Seksik P, Auzolle C, Munoz-Bongrand N, et al
    Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Am J Gastroenterol. 2017;112:337-345.
    PubMed     Abstract available


  218. JEURING SF, van den Heuvel TR, Liu LY, Zeegers MP, et al
    Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2017;112:325-336.
    PubMed     Abstract available


    January 2017
  219. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  220. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed    


  221. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  222. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed    


  223. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed    


  224. CUI DJ, Zhao X, Hu M
    Impact of Crohn's Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2017;112:185.
    PubMed    


    December 2016
  225. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  226. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed    


    November 2016
  227. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed    


    October 2016
  228. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  229. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Abstract available



  230. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    



  231. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    



  232. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    



  233. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    


  234. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed    


  235. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Abstract available


    June 2016
  236. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed    


    May 2016
  237. DEEPAK P, Fletcher JG, Fidler JL, Barlow JM, et al
    Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: